Association between Free Thyroxine Levels and Diabetic Retinopathy in Euthyroid Patients with Type 2 Diabetes Mellitus

References

• Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124–136. doi:10.1016/S0140-6736(09)62124-3.
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–564. doi:10.2337/dc11-1909.
   PubMed Web of Science ®Google Scholar
• Leasher JL, Bourne RR, Flaxman SR, et al. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care. 2016;39:1643–1649. doi:10.2337/dc15-2171.
   PubMed Web of Science ®Google Scholar
• Wong TY, Cheung CM, Larsen M, Sharma S, Simo R. Diabetic retinopathy. Nat Rev Dis Primers. 2016;2:16012. doi:10.1038/nrdp.2016.12.
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–1589. doi:10.1056/NEJMoa0806470.
   PubMed Web of Science ®Google Scholar
• Zhang L, Krzentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care. 2001;24:1275–1279. doi:10.2337/diacare.24.7.1275.
   PubMed Web of Science ®Google Scholar
• Guastamacchia E, Triggiani V, Aglialoro A, et al. Italian association of clinical endocrinologists (AME) & Italian association of clinical diabetologists (AMD) position statement: diabetes mellitus and thyroid disorders: recommendations for clinical practice. Endocrine. 2015;49:339–352. doi:10.1007/s12020-014-0474-9.
   PubMed Web of Science ®Google Scholar
• Wu J, Yue S, Geng J, et al. Relationship between diabetic retinopathy and subclinical hypothyroidism: a meta-analysis. Sci Rep. 2015;5:12212. doi:10.1038/srep12212.
   PubMed Web of Science ®Google Scholar
• Jabbar A, Pingitore A, Pearce SH, et al. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14:39–55. doi:10.1038/nrcardio.2016.174.
   PubMed Web of Science ®Google Scholar
• Han C, He X, Xia X, et al. Subclinical hypothyroidism and type 2 diabetes: a systematic review and meta-analysis. PLoS One. 2015;10:e0135233. doi:10.1371/journal.pone.0135233.
   PubMed Web of Science ®Google Scholar
• Yang JK, Liu W, Shi J, Li YB. An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients. Diabetes Care. 2010;33:1018–1020. doi:10.2337/dc09-1784.
   PubMed Web of Science ®Google Scholar
• Wu J, Li X, Tao Y, Wang Y, Peng Y. Free triiodothyronine levels are associated with diabetic nephropathy in euthyroid patients with type 2 diabetes. Int J Endocrinol. 2015;2015:204893. doi:10.1155/2015/204893.
   PubMed Web of Science ®Google Scholar
• Kim BY, Kim CH, Jung CH, et al. Association between subclinical hypothyroidism and severe diabetic retinopathy in Korean patients with type 2 diabetes. Endocr J. 2011;58:1065–1070. doi:10.1507/endocrj.EJ11-0199.
   PubMed Web of Science ®Google Scholar
• Sawant O, Horton AM, Shukla M, et al. Light-regulated thyroid hormone signaling is required for rod photoreceptor development in the mouse retina. Invest Ophthalmol Vis Sci. 2015;56:8248–8257. doi:10.1167/iovs.15-17743.
   PubMed Web of Science ®Google Scholar
• Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412–419. doi:10.1136/bmj.321.7258.412.
   PubMed Web of Science ®Google Scholar
• Anonymous. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–853. doi:10.1016/S0140-6736(98)07019-6.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102:527–532. doi:10.1001/archopht.1984.01040030405011.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102:520–526. doi:10.1001/archopht.1984.01040030398010.
   PubMed Web of Science ®Google Scholar
• Lim LS, Wong TY. Lipids and diabetic retinopathy. Expert Opin Biol Ther. 2012;12:93–105. doi:10.1517/14712598.2012.641531.
   PubMed Web of Science ®Google Scholar
• Wong CW, Wong TY, Cheng CY, Sabanayagam C. Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. Kidney Int. 2014;85:1290–1302. doi:10.1038/ki.2013.491.
   PubMed Web of Science ®Google Scholar
• Cheung N, Wong TY. Obesity and eye diseases. Surv Ophthalmol. 2007;52:180–195. doi:10.1016/j.survophthal.2006.12.003.
   PubMed Web of Science ®Google Scholar
• Sasongko MB, Wong TY, Nguyen TT, et al. Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids. Diabetes Care. 2011;34:474–479. doi:10.2337/dc10-0793.
   PubMed Web of Science ®Google Scholar
• Sasongko MB, Wong TY, Nguyen TT, et al. Novel versus traditional risk markers for diabetic retinopathy. Diabetologia. 2012;55:666–670. doi:10.1007/s00125-011-2424-x.
   PubMed Web of Science ®Google Scholar
• Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116:1725–1735. doi:10.1161/CIRCULATIONAHA.106.678326.
   PubMed Web of Science ®Google Scholar
• Gumieniak O, Perlstein TS, Hopkins PN, et al. Thyroid function and blood pressure homeostasis in euthyroid subjects. J Clin Endocrinol Metab. 2004;89:3455–3461. doi:10.1210/jc.2003-032143.
   PubMed Web of Science ®Google Scholar
• Jun JE, Jin SM, Jee JH, et al. TSH increment and the risk of incident type 2 diabetes mellitus in euthyroid subjects. Endocrine. 2017;55:944–953. doi:10.1007/s12020-016-1221-1.
   PubMed Web of Science ®Google Scholar
• Ortega E, Koska J, Pannacciulli N, Bunt JC, Krakoff J. Free triiodothyronine plasma concentrations are positively associated with insulin secretion in euthyroid individuals. Eur J Endocrinol. 2008;158:217–221. doi:10.1530/EJE-07-0592.
   PubMed Web of Science ®Google Scholar
• Martinez B, Ortiz RM. Thyroid hormone regulation and insulin resistance: insights from animals naturally adapted to fasting. Physiology (Bethesda). 2017;32:141–151. doi:10.1152/physiol.00018.2016.
   PubMed Web of Science ®Google Scholar
• Lekakis J, Papamichael C, Alevizaki M, et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid. 1997;7:411–414. doi:10.1089/thy.1997.7.411.
   PubMed Web of Science ®Google Scholar
• Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111–1115. doi:10.1016/0140-6736(92)93147-F.
   PubMed Web of Science ®Google Scholar
• Simo R, Hernandez C. European consortium for the early treatment of diabetic R. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab. 2014;25:23–33. doi:10.1016/j.tem.2013.09.005.
   PubMed Web of Science ®Google Scholar
• Zhang SX, Sanders E, Fliesler SJ, Wang JJ. Endoplasmic reticulum stress and the unfolded protein responses in retinal degeneration. Exp Eye Res. 2014;125:30–40. doi:10.1016/j.exer.2014.04.015.
   PubMed Web of Science ®Google Scholar
• Villanueva I, Alva-Sanchez C, Pacheco-Rosado J. The role of thyroid hormones as inductors of oxidative stress and neurodegeneration. Oxid Med Cell Longev. 2013;2013:218145. doi:10.1155/2013/218145.
   PubMed Web of Science ®Google Scholar
• Ceresini G, Lauretani F, Maggio M, et al. Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study. J Am Geriatr Soc. 2009;57:89–93. doi:10.1111/(ISSN)1532-5415.
   PubMed Web of Science ®Google Scholar
• Fu AL, Zhou CY, Chen X. Thyroid hormone prevents cognitive deficit in a mouse model of Alzheimer’s disease. Neuropharmacology. 2010;58:722–729. doi:10.1016/j.neuropharm.2009.12.020.
   PubMed Web of Science ®Google Scholar
• Faggiano A, Del Prete M, Marciello F, et al. Thyroid diseases in elderly. Minerva Endocrinol. 2011;36:211–231.
   PubMed Web of Science ®Google Scholar
• Boucai L, Surks MI. Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin Endocrinol (Oxf). 2009;70:788–793. doi:10.1111/j.1365-2265.2008.03390.x.
   PubMed Web of Science ®Google Scholar
• Santos-Palacios S, Brugos-Larumbe A, Guillen-Grima F, Garmendia-Madariaga A, Galofre JC. Does metformin have a “buffer effect” on serum TSH levels in euthyroid diabetic patients? Hormones (Athens). 2015;14:280–285.
   PubMedGoogle Scholar
• He X, Wu D, Hu C, et al. Role of metformin in the treatment of patients with thyroid nodules and insulin resistance: a systematic review and meta-analysis. Thyroid. 2019;29:359–367. doi:10.1089/thy.2017.0707.
   PubMed Web of Science ®Google Scholar